Wladimir Hogenhuis - Net Worth and Insider Trading

Wladimir Hogenhuis Net Worth

The estimated net worth of Wladimir Hogenhuis is at least $189,292 dollars as of 2024-06-06. Wladimir Hogenhuis is the Director of Rezolute Inc and owns about 32,693 shares of Rezolute Inc (RZLT) stock worth over $189,292. Details can be seen in Wladimir Hogenhuis's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Wladimir Hogenhuis has not made any transactions after 2022-05-04 and currently still holds the listed stock(s).

Transaction Summary of Wladimir Hogenhuis

To

Wladimir Hogenhuis Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wladimir Hogenhuis owns 2 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , and Rezolute Inc (RZLT) .

Click here to see the complete history of Wladimir Hogenhuis’s form 4 insider trades.

Insider Ownership Summary of Wladimir Hogenhuis

Ticker Comapny Transaction Date Type of Owner
RARE Ultragenyx Pharmaceutical Inc 2018-09-28 Chief Operating Officer
RZLT Rezolute Inc 2022-05-04 director

Wladimir Hogenhuis Latest Holdings Summary

Wladimir Hogenhuis currently owns a total of 1 stock. Wladimir Hogenhuis owns 32,693 shares of Rezolute Inc (RZLT) as of May 4, 2022, with a value of $189,292.

Latest Holdings of Wladimir Hogenhuis

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RZLT Rezolute Inc 2022-05-04 32,693 5.79 189,292

Holding Weightings of Wladimir Hogenhuis


Wladimir Hogenhuis Form 4 Trading Tracker

According to the SEC Form 4 filings, Wladimir Hogenhuis has made a total of 1 transactions in Rezolute Inc (RZLT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Rezolute Inc is the acquisition of 32,693 shares on May 4, 2022, which cost Wladimir Hogenhuis around $145,157.

Insider Trading History of Wladimir Hogenhuis

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Wladimir Hogenhuis Trading Performance

GuruFocus tracks the stock performance after each of Wladimir Hogenhuis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wladimir Hogenhuis is -15.12%. GuruFocus also compares Wladimir Hogenhuis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wladimir Hogenhuis within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Wladimir Hogenhuis's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Wladimir Hogenhuis

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -25.2 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -20.74 LIMIT LIMIT LIMIT LIMIT LIMIT

Wladimir Hogenhuis Ownership Network

Ownership Network List of Wladimir Hogenhuis

No Data

Ownership Network Relation of Wladimir Hogenhuis

Insider Network Chart

Wladimir Hogenhuis Owned Company Details

What does Ultragenyx Pharmaceutical Inc do?

Who are the key executives at Ultragenyx Pharmaceutical Inc?

Wladimir Hogenhuis is the Chief Operating Officer of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include EVP and Chief Medical Officer Eric Crombez , CBO & Senior Vice President Thomas Richard Kassberg , and EVP & Chief Commercial Officer Erik Harris .

Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary

Over the past 18 months, Wladimir Hogenhuis made no insider transaction in Ultragenyx Pharmaceutical Inc (RARE). Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 5,605 shares made by Theodore Alan Huizenga , a net sale of 127,435 shares made by Emil D Kakkis , and a net sale of 54,366 shares made by Thomas Richard Kassberg .

In summary, during the past 3 months, insiders sold 24,200 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 24,200 shares. During the past 18 months, 243,647 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 243,647 shares.

Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ultragenyx Pharmaceutical Inc Insider Transactions

No Available Data

Wladimir Hogenhuis Mailing Address

Above is the net worth, insider trading, and ownership report for Wladimir Hogenhuis. You might contact Wladimir Hogenhuis via mailing address: 60 Leveroni Court, Novato Ca 94949.

Discussions on Wladimir Hogenhuis

No discussions yet.